Suchergebnisse - "Research Support, N.I.H., Extramural"

PubPharm (73.268)

1

COVID vaccine efficacy against the B.1.351 ("South African") variant-The urgent need to lay the groundwork for possible future challenge studies

enthalten in: Human vaccines & immunotherapeutics | 2022

von Eyal, N. | Caplan, A. | Plotkin, S.

2

Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants

enthalten in: Human vaccines & immunotherapeutics | 2022

von Huang, Y. | Zhang, L. | Eaton, A. | +18

3

A tribute to Charlotte S. Catz, MD

enthalten in: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians | 2022

von Romero, R.

4

The effects of osteopathic manipulative treatment on pain and disability in patients with chronic neck pain : A single-blinded randomized controlled trial

enthalten in: PM & R : the journal of injury, function, and rehabilitation | 2022

von Cholewicki, J. | Popovich, J. | Reeves, N. | +11

5

LDB1-mediated transcriptional complexes are sensitive to islet stress

enthalten in: Islets | 2022

von Liu, Y. | Kepple, J. | Shalev, A. | +1

6

HeAlth System StrEngThening in four sub-Saharan African countries (ASSET) to achieve high-quality, evidence-informed surgical, maternal and newborn, and primary care : protocol for pre-implementation phase studies

enthalten in: Global health action | 2022

von Seward, N. | Hanlon, C. | Abdella, A. | +35

7

Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy

enthalten in: Cancer biology & therapy | 2022

von Staudt, R. | Carlson, R. | Snook, A.

8

Drugging the undruggable : activity-based protein profiling offers opportunities for targeting the KLK activome

enthalten in: Cancer biology & therapy | 2022

von Lee, K. | Chau, C. | Price, D. | +1

CommentIn: Cancer Biol Ther. 2022 Dec 31;23(1):401-403. - PMID 35652924

9

Feasibility and safety of targeting mitochondria for cancer therapy - preclinical characterization of gamitrinib, a first-in-class, mitochondriaL-targeted small molecule Hsp90 inhibitor

enthalten in: Cancer biology & therapy | 2022

von Hayat, U. | Elliott, G. | Olszanski, A. | +1

10

CRC-derived exosomes containing the RNA binding protein HuR promote lung cell proliferation by stabilizing c-Myc mRNA

enthalten in: Cancer biology & therapy | 2022

von Xiao, H. | Ye, X. | Vishwakarma, V. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[7327]